Rare Diseases Research: Clinical Trial for Niemann-Pick Type C
https://www.einstein.yu.edu - Determined to find a treatment for children with the degenerative brain disease Niemann-Pick Type C, Steven Walkley, D.V.M., Ph.D., turned a serendipitous laboratory discovery into a successful national research collaboration with other academic institutions and the National Center for Advancing Translational Sciences' program for rare diseases (Therapeutics for Rare and Neglected Diseases). These efforts led to an NIH Phase 1 clinical trial testing cyclodextrin as a therapy for children with this disease. Dr. Walkley is a professor in the Dominick P. Purpura Department of Neuroscience and director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center at Albert Einstein College of Medicine.
Born With 2% Brain, Now Defying Science | The Boy With No Brain
Colin Farrell Opens Up About His Son With Angelman Syndrome | PEOPLE
Niemann-Pick disease Type C - causes, symptoms, diagnosis, treatment, pathology
Case Study 180 | Neimann-Pick Disease Type C | Explained by Dr. Betsy Grunch
The Lethal Drug Trial That Turned Men Into Elephants
Serial Killers Seem To Be Disappearing. Here's Why | Criminal Psychology
Liam Mitchell Niemann-Pick Type C
This Young Man Is One Of Two People In The World Coping With A Rare, Nameless Disease | NBC News
What is Niemann-Pick Type C?
National Fabry Disease Foundation Awareness Video HD
Your Brain: Who's in Control? | Full Documentary | NOVA | PBS
Sisters battle rare, fatal genetic disease found in 100 people worldwide
Niemann Pick Type C - Georgina's story
NPC PFDD - Overview of Niemann-Pick Type C Disease and Current Treatments
Treating Niemann-Pick Disease Type C
WEBINAR “Niemann-Pick Type C: Two Genes - Many Clinical Pictures - One Unifying Biomarker”
My Story | Living with Schizophrenia
Living With Pompe Disease – Shaylee’s Story
Valley baby showing great progress with experimental Niemann-Pick Type C disease drug treatments
